Health Products

CanSui, Lexscl Fat Rapid Loss Capsule, The Extreme-thin Fat Burning Bomb, Xiu Zhi Su L-Carnitine Slimming Capsule

· Published by Health Canada · Official notice

Details

Alert type: Foreign Product Alert (FPA)
Category: Natural health products
Issue: Product Safety, Undeclared Substance
Audience: General Public
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Images

Details

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Source of alert

Hong Kong Department of Health

Product names

  • CanSui
  • Lexscl Fat Rapid Loss Capsule
  • The Extreme-thin Fat Burning Bomb
  • Xiu Zhi Su L-Carnitine Slimming Capsule

Manufacturer / Place of origin

Unknown

Product description

These products are promoted for weight loss.

Reason for warning

The Hong Kong Department of Health (DH) warned consumers not to use the Extreme-thin Fat Burning Bomb because it was found to contain undeclared sibutramine. The DH warned consumers not to use CanSui, Lexscl Fat Rapid Loss Capsule, and Xiu Zhi Su L-Carnitine Slimming Capsule because they were found to contain undeclared sibutramine and phenolphthalein.

Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke.

Phenolphthalein was previously used as a laxative but is no longer authorized for sale in Canada because it may cause cancer.

According to the Hong Kong Department of Health press releases:

CanSui was investigated by the Hong Kong Department of Health after a local hospital authority reported that a 20-year-old woman was admitted to a hospital in Hong Kong because of acute psychosis. She had a history of consuming CanSui, and drug-related psychosis was suspected. The woman was later discharged. She had purchased the product over the Internet.

Lexscl Fat Rapid Loss Capsule was tested as part of a Hong Kong Department of Health surveillance investigation and had been purchased by the Hong Kong Department of Health from an Internet auction website.

The Extreme-thin Fat Burning Bomb was investigated by the Hong Kong Department of Health after a local hospital authority reported that a 52-year-old woman was admitted to a hospital in Hong Kong because of dizziness and heart palpitations. She reported a history of consuming the Extreme-thin Fat Burning Bomb, and a drug-related adverse reaction was suspected. The woman was later discharged.

Xiu Zhi Su L-Carnitine Slimming Capsule was investigated by the Hong Kong Department of Health after a local hospital authority reported that a 21-year-old woman was admitted to a hospital in Hong Kong because of shortness of breath and heart palpitations. She reported a history of consuming Xiu Zhi Su L-Carnitine Slimming Capsule, and a drug-related adverse reaction was suspected. The woman was later discharged. She had purchased the product over the Internet.

Possible side effects

In addition to heart attack and stroke, side effects associated with sibutramine include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.

Additional side effects associated with phenolphthalein include decreased blood pressure, skin rash and gastrointestinal bleeding.

What you should do

Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.

Background

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.

Report a health or safety concern

  • Call toll-free at 1-866-234-2345.
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Media enquiries

Health Canada
613-957-2983

Public enquiries

613-957-2991
1-866-225-0709
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime